Armed With New Data, Researchers Again Challenge Effectiveness of Antiflu Drug
New study questions strategy of stockpiling oseltamivir in case of flu pandemics (Source: ScienceNOW)
Source: ScienceNOW - April 9, 2014 Category: Science Source Type: news
Tamiflu-resistant influenza related to mutations in genome
It doesn't take long for the flu virus to outsmart Tamiflu. Scientists have developed a tool that reveals the mutations that make the virus resistant, and they have identified new mutations that may render ineffective one of the few treatments currently available on the market. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 31, 2014 Category: Science Source Type: news
Tamiflu-resistant influenza: Parsing the genome for the culprits
(Ecole Polytechnique Fédérale de Lausanne) It doesn't take long for the flu virus to outsmart Tamiflu. EPFL scientists have developed a tool that reveals the mutations that make the virus resistant, and they have identified new mutations that may render ineffective one of the few treatments currently available on the market. Their research is published in PLOS Genetics. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 31, 2014 Category: Biology Source Type: news
Clonal Expansion of H274Y pH1N1 Tamiflu Resistance In PA
The commentary discusses the clonal expansion of H274Y pH1N1 Tamiflu resistance in Pennsylvania in 2014. (03/28/14 23:45) (Source: Recombinomics)
Source: Recombinomics - March 29, 2014 Category: Infectious Diseases Source Type: news
Well: Antiviral Drugs Cut Flu Deaths, Study Finds
Tamiflu and its siblings reduced the mortality rate in hospitalized patients by as much as 50 percent, researchers say. (Source: NYT)
Source: NYT - March 28, 2014 Category: American Health Authors: By NICHOLAS BAKALAR Tags: Influenza Body medicine and health Featured Tamiflu (Drug) Source Type: news
European Panel Endorses Generic Version of OseltamivirEuropean Panel Endorses Generic Version of Oseltamivir
Ebilfumin was shown to be bioequivalent to the brand-name product Tamiflu. International Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 21, 2014 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news
Tamiflu® reduces risk of death by 25% in adults hospitalised with H1N1 pandemic influenza
Adults hospitalised with H1N1 influenza during the 2009-2010 pandemic were 25% less likely to die from the disease if they were given antiviral drugs called neuraminidase inhibitors (NAIs) such as Tamiflu®, according to a large meta-analysis involving more than 29 000 patients from 38 countries, published in The Lancet Respiratory Medicine journal. The findings also indicate that treatment within 2 days of flu symptoms developing halved the risk of death compared with later treatment or no treatment."Many governments have stockpiles of Tamiflu that are close to expiry. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 19, 2014 Category: Consumer Health News Tags: Flu / Cold / SARS Source Type: news
Roche-backed study finds Tamiflu saved lives in flu pandemic
LONDON (Reuters) - Using Roche's medicine Tamiflu saved lives during the H1N1 swine flu pandemic four years ago, according to a new scientific study published on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - March 19, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
Tamiflu reduced risk of death in H1N1 influenza pandemic
Hospitalised patients who took Tamiflu were 25 % less likely to dieRelated items from OnMedicaSpending watchdog criticises government over TamifluDrug giant agrees to release all Tamiflu trial dataSwine flu jab very effectiveSwine flu deaths cut by blood oxygenationPandemic flu death toll could be 15 times higher (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 19, 2014 Category: UK Health Source Type: news
Tamiflu Saved Lives During Swine Flu Pandemic, Study Confirms
Best to start treatment within 48 hours, experts saySource: HealthDay
Related MedlinePlus Pages: H1N1 Flu (Swine Flu), Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 18, 2014 Category: Consumer Health News Source Type: news
Natco Pharma gets USFDA tentative nod for generic Tamiflu
The tentative approval of Oseltamivir Phosphate capsules by the US Food and Drug Administration is for multiple strengths of 30mg, 45 mg and 75 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 18, 2014 Category: Pharmaceuticals Source Type: news
Statins have no side effects? This is what our study really found … | Ben Goldacre
This article first appeared on Ben Goldacre's own website, Bad ScienceDrugsPlacebo effectMedical researchHealthBen Goldacretheguardian.com © 2014 Guardian News and Media Limited or its affiliated companies. All rights reserved. | Use of this content is subject to our Terms & Conditions | More Feeds (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 14, 2014 Category: Science Authors: Ben Goldacre Tags: theguardian.com Blogposts Placebo effect Health Medical research Society Drugs Science Source Type: news
Genentech Resolves Tamiflu Shortage
Roche/Genentech announced that the shortage of the liquid form of Tamiflu in the US has been resolved. The shortage occurred during the flu season, but lasted less than two weeks. The FDA has already taken the product off its drug shortage list. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - January 21, 2014 Category: Pharmaceuticals Source Type: news
